DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Tewari KS, Burger RA, Enserro D. et al.
Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer.
J Clin Oncol 2019;
37 (26) 2317-2328
DOI: 10.1200/JCO.19.01009.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.